Association of cytokines with exosomes in the plasma of HIV-1-seropositive individuals

Journal of Infectious Diseases

Volumn 211, Issue 11, 2015, Pages 1712-1716

  Konadu, Kateena Addae ^a   Chu, Jane ^a   Huang, Ming Bo ^a   Amancha, Praveen Kumar ^a   Armstrong, Wendy ^a   Powell, Michael D ^a   Villinger, Francois ^a   Bond, Vincent C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chemokines; cytokines; exosomes; HIV; immune activation

Indexed keywords

CD38 ANTIGEN; CHEMOKINE; CYTOKINE;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; EXOSOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRION; VIRUS LOAD; BLOOD; CHEMISTRY; COHORT ANALYSIS; HIV INFECTIONS; IMMUNOLOGY;

COHORT STUDIES; CYTOKINES; EXOSOMES; HIV INFECTIONS; HIV-1; HUMANS;

EID: 84930448119     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu676     Document Type: Article

References (15)

1. Bofill M, Mocroft A, Lipman M, et al. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996; 10:827-34.
2. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92.
3. Katsikis PD, Mueller YM, Villinger F. The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? PLoS Pathog 2011; 7:e1002055.
4. Meckes DG Jr, Raab-Traub N. Microvesicles and viral infection. J Virol 2011; 85:12844-54.
5. Campbell TD, Khan M, Huang MB, Bond VC, Powell MD. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis 2008; 18(2 suppl 2):S2-9.
6. Muratori C, Cavallin LE, Kratzel K, et al. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 2009; 6:218-30.
7. Lenassi M, Cagney G, Liao M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4 T cells. Traffic 2009; 11:110-21.
8. Raymond AD, Campbell-Sims TC, Khan M, et al. HIV type 1 Nef is released from infected cells in CD45+ microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses 2011; 27:167-78.
9. Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cellfree supernatants. J Immunol Methods 2008; 338:21-30.
10. Hua S, Lecuroux C, Saez-Cirion A, et al. Potential role for HIV-Specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers . PLoS One 2014; 9:e101920.
11. Tannetta D, Dragovic R, Alyahyaei Z, Southcombe J. Extracellular vesicles and reproduction-promotion of successful pregnancy. Cell Mol Immunol 2014; 11:548-63.
12. Altevogt P, Bretz NP, Ridinger J, Utikal J, Umansky V. Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. Semin Cancer Biol 2014; 28C:51-7.
13. Gehrmann U, Naslund TI, Hiltbrunner S, Larssen P, Gabrielsson S. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin Cancer Biol 2014; 28C:58-67.
14. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012; 83:1484-94.
15. Ali SA, Huang MB, Campbell PE, et al. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retroviruses 2010; 26:173-92.